WeChat Contact
Home / Articles / Can Tranexamic Acid Be Used to Treat Men...

Can Tranexamic Acid Be Used to Treat Menorrhagia?

Jul 26, 2026 5 views
Disclaimer: This site is a medical service platform; some page content is AI-assisted. Health-related information does not constitute medical advice. If you have any questions, please consult a healthcare professional. See full disclaimer

Tranexamic acid is an antifibrinolytic medication widely used to reduce excessive bleeding in various clinical settings—including heavy menstrual bleeding (menorrhagia). While it does not treat the un

Tranexamic acid is an antifibrinolytic medication widely used to reduce excessive bleeding in various clinical settings—including heavy menstrual bleeding (menorrhagia). While it does not treat the underlying cause of abnormal uterine bleeding, it effectively reduces blood loss by inhibiting plasmin-mediated fibrinolysis, thereby stabilizing blood clots formed in the endometrium.

Clinical guidelines—including those from the American College of Obstetricians and Gynecologists (ACOG) and the UK’s National Institute for Health and Care Excellence (NICE)—recommend tranexamic acid as a first-line pharmacologic option for women with heavy menstrual bleeding who are not candidates for or prefer to avoid hormonal therapy. It is typically prescribed at a dose of 1,300 mg orally three times daily for up to five days per cycle, starting with the onset of menses.

However, its use in cases of prolonged or irregular bleeding—such as “prolonged menstrual spotting” or “menstrual bleeding that fails to resolve”—requires careful evaluation. Persistent or intermenstrual bleeding may signal structural abnormalities (e.g., polyps, fibroids), endometrial hyperplasia, malignancy, or systemic disorders (e.g., coagulopathies, thyroid dysfunction). Tranexamic acid alone is not appropriate as initial management in such scenarios; diagnostic workup—including pelvic ultrasound, endometrial biopsy when indicated, and hormonal or hematologic testing—is essential before initiating treatment.

Contraindications include active thromboembolic disease, history of venous thromboembolism (VTE), disseminated intravascular coagulation (DIC), or concurrent use of other prothrombotic agents. Caution is advised in patients with renal impairment, as tranexamic acid is primarily excreted unchanged by the kidneys.

In summary, tranexamic acid is evidence-based and effective for reducing objectively heavy menstrual flow but should not be used empirically for unexplained, persistent, or irregular uterine bleeding without thorough diagnostic assessment.

AI Medical Advisor

Hello! I'm ChinaMedical AI Assistant. I can help you with information about medical tourism in China, hospital recommendations, treatment costs, medical visas, and more. How can I help you?